* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
6261RYR1C0024591Malignant hyperpyrexia due to anesthesia0.798598893346645BEFREE;CTD_human;GAD;HPO;LHGDN;MGD;ORPHANET;UNIPROT
6261RYR1C0751951Central Core Myopathy (disorder)0.725713372787737BEFREE;CTD_human;GAD;LHGDN;MGD;ORPHANET;UNIPROT
6261RYR1C1850674MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA (disorder)0.684670355331623BEFREE;CTD_human;MGD;ORPHANET;UNIPROT
6261RYR1C0026848Myopathy0.226041622990976BEFREE;HPO;LHGDN
6261RYR1C0009917Contracture0.207952721364863BEFREE;HPO;LHGDN
6261RYR1C0035410Rhabdomyolysis0.202732912464814HPO;LHGDN
6261RYR1C0162292External Ophthalmoplegia0.200824180352639BEFREE;HPO
6261RYR1C1840365King Denborough syndrome0.200824180352639BEFREE;ORPHANET
6261RYR1C0427055Facial Paresis0.200274726784213BEFREE;HPO
6261RYR1C0700208Acquired scoliosis0.200274726784213BEFREE;HPO
6261RYR1C0746674Generalized muscle weakness0.200274726784213BEFREE;HPO
6261RYR1C1854678MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE0.200274726784213BEFREE;ORPHANET
6261RYR1C2267233Neonatal Hypotonia0.200274726784213BEFREE;HPO
6261RYR1C0005745Blepharoptosis0.2HPO
6261RYR1C0005779Blood Coagulation Disorders0.2HPO
6261RYR1C0007134Renal Cell Carcinoma0.2CTD_human
6261RYR1C0007193Cardiomyopathy, Dilated0.2HPO
6261RYR1C0009918Contracture of joint0.2HPO
6261RYR1C0011168Deglutition Disorders0.2HPO
6261RYR1C0015967Fever0.2HPO
6261RYR1C0016202Flatfoot0.2HPO
6261RYR1C0019555Hip Dislocation, Congenital0.2HPO
6261RYR1C0020224Polyhydramnios0.2HPO
6261RYR1C0020305Hydrops Fetalis0.2HPO
6261RYR1C0020461Hyperkalemia0.2HPO
6261RYR1C0020649Hypotension0.2HPO
6261RYR1C0026827Muscle hypotonia0.2HPO
6261RYR1C0026837Muscle Rigidity0.2HPO
6261RYR1C0026850Muscular Dystrophy0.2HPO
6261RYR1C0027080Myoglobinuria0.2HPO
6261RYR1C0035229Respiratory Insufficiency0.2HPO
6261RYR1C0037932Curvature of spine0.2HPO
6261RYR1C0039231Tachycardia0.2HPO
6261RYR1C0085681Hyperphosphatemia (disorder)0.2HPO
6261RYR1C0086437Joint laxity0.2HPO
6261RYR1C0151576Elevated creatine kinase0.2HPO
6261RYR1C0162674Chronic progressive external ophthalmoplegia0.2HPO
6261RYR1C0221629Proximal muscle weakness0.2HPO
6261RYR1C0231246Failure to gain weight0.2HPO
6261RYR1C0232466Feeding difficulties0.2HPO
6261RYR1C0234146Absent reflex0.2HPO
6261RYR1C0234860Weak cry0.2HPO
6261RYR1C0234958muscle degeneration0.2HPO
6261RYR1C0235659Reduced fetal movement0.2HPO
6261RYR1C0240635Byzanthine arch palate0.2HPO
6261RYR1C0241005Creatine phosphokinase serum increased0.2HPO
6261RYR1C0241772Reflex, Deep Tendon, Absent0.2HPO
6261RYR1C0264133Acquired flat foot0.2HPO
6261RYR1C0265783Congenital hypoplasia of lung0.2HPO
6261RYR1C0270948Neurogenic Muscular Atrophy0.2HPO
6261RYR1C0278124Absent tendon reflex0.2HPO
6261RYR1C0332615Myopathic facies0.2HPO
6261RYR1C0333068Flexion contracture0.2HPO
6261RYR1C0376175Bell Palsy0.2HPO
6261RYR1C0541794Skeletal muscle atrophy0.2HPO
6261RYR1C0553706SERUM PHOSPHATE ELEVATED0.2HPO
6261RYR1C0560346Difficulty running0.2HPO
6261RYR1C0575158Kyphoscoliosis deformity of spine0.2HPO
6261RYR1C0752282Congenital Structural Myopathy0.2CTD_human
6261RYR1C1184923Lumbar lordosis0.2HPO
6261RYR1C1301959Bulbar weakness0.2HPO
6261RYR1C1834558Myopathy, Centronuclear, Autosomal Dominant0.2ORPHANET
6261RYR1C1836047Long face0.2HPO
6261RYR1C1837463Narrow face0.2HPO
6261RYR1C1837514Phenotypic variability0.2HPO
6261RYR1C1838869Proximal neurogenic muscle weakness0.2HPO
6261RYR1C1839039Highly variable clinical phenotype0.2HPO
6261RYR1C1840372Mixed respiratory and metabolic acidosis0.2HPO
6261RYR1C1842170Centrally nucleated skeletal muscle fibers0.2HPO
6261RYR1C1843479Neurogenic muscle atrophy, especially in the lower limbs0.2HPO
6261RYR1C1843697Axial muscle weakness0.2HPO
6261RYR1C1843700Variation in muscle fiber size0.2HPO
6261RYR1C1848924Infantile onset0.2HPO
6261RYR1C1849121Thin face0.2HPO
6261RYR1C1850530Flexion contractures of joints0.2HPO
6261RYR1C1850667Highly variable phenotype and severity0.2HPO
6261RYR1C1850830Exercise-induced myalgia0.2HPO
6261RYR1C1854301Motor delay0.2HPO
6261RYR1C1854387Type 1 muscle fiber predominance0.2HPO
6261RYR1C1854494Slow progression0.2HPO
6261RYR1C1855106Neonatal onset0.2HPO
6261RYR1C1858719Facial muscle weakness of muscles innervated by CN VII0.2HPO
6261RYR1C1861403Variable expressivity0.2HPO
6261RYR1C1864711Muscle biopsy shows dystrophic changes0.2HPO
6261RYR1C1866021Increased connective tissue0.2HPO
6261RYR1C1866210Highly variable phenotype, even within families0.2HPO
6261RYR1C1866862Highly variable severity0.2HPO
6261RYR1C2315100Pediatric failure to thrive0.2HPO
6261RYR1C2674608Feeding difficulties in infancy0.2HPO
6261RYR1C2752013Prenatal onset0.2HPO
6261RYR1C2930980Malignant hyperthermia susceptibility type 10.2CTD_human
6261RYR1C3806467Respiratory insufficiency due to muscle weakness0.2HPO
6261RYR1C3806482Recurrent respiratory infections0.2HPO
6261RYR1C3808039Nemaline rods0.2HPO
6261RYR1C3839460Nonprogressive0.2HPO
6261RYR1C4020855Respiratory function loss0.2HPO
6261RYR1C4020868Elevated heart rate0.2HPO
6261RYR1C4020874No development of motor milestones0.2HPO
6261RYR1C4020899Autosomal recessive predisposition0.2HPO
6261RYR1C4025568Type 1 and type 2 muscle fiber minicore regions0.2HPO
6261RYR1C4025571Type 1 fibers relatively smaller than type 2 fibers0.2HPO
6261RYR1C4082299Bulbar palsy0.2HPO
6261RYR1C0270960Congenital myopathy (disorder)0.0087912570948192BEFREE
6261RYR1C0270962Multi-core congenital myopathy0.0038461749789834BEFREE
6261RYR1C0029089Ophthalmoplegia0.00355709281745305BEFREE;LHGDN
6261RYR1C0206157Myopathies, Nemaline0.00328236603323995BEFREE;LHGDN
6261RYR1C0000768Congenital Abnormality0.00300763924902685BEFREE;LHGDN
6261RYR1C0003811Cardiac Arrhythmia0.00273291246481375LHGDN
6261RYR1C0011071Sudden death0.00273291246481375LHGDN
6261RYR1C0024299Lymphoma0.00273291246481375LHGDN
6261RYR1C3714514Infection0.00273291246481375LHGDN
6261RYR1C0376358Malignant neoplasm of prostate0.0026817553075011BEFREE;GAD
6261RYR1C1276035Pena-Shokeir syndrome type I0.0026817553075011BEFREE;GAD
6261RYR1C0008928Cleidocranial Dysplasia0.0024725410579179BEFREE
6261RYR1C0020503Hyperparathyroidism, Secondary0.002407028523288GAD
6261RYR1C0040336Tobacco Use Disorder0.002407028523288GAD
6261RYR1C0027868Neuromuscular Diseases0.0019230874894917BEFREE
6261RYR1C0015230Exanthema0.0016483607052786BEFREE
6261RYR1C0030552Paresis0.0016483607052786BEFREE
6261RYR1C0151786Muscle Weakness0.0016483607052786BEFREE
6261RYR1C0848332Spots on skin0.0016483607052786BEFREE
6261RYR1C0175709Centronuclear myopathy0.0013736339210655BEFREE
6261RYR1C0278134Absence of sensation0.0008241803526393BEFREE
6261RYR1C3899989Autosomal Dominant Disorder0.0008241803526393BEFREE
6261RYR1C0018801Heart failure0.0005494535684262BEFREE
6261RYR1C0018802Congestive heart failure0.0005494535684262BEFREE
6261RYR1C0020538Hypertensive disease0.0005494535684262BEFREE
6261RYR1C0027126Myotonic Dystrophy0.0005494535684262BEFREE
6261RYR1C0038454Cerebrovascular accident0.0005494535684262BEFREE
6261RYR1C0410158Muscle damage0.0005494535684262BEFREE
6261RYR1C0546264Congenital Fiber Type Disproportion0.0005494535684262BEFREE
6261RYR1C3887505DYSFUNCTION - SKIN DISORDERS0.0005494535684262BEFREE
6261RYR1C0005129Bernard-Soulier Syndrome0.0002747267842131BEFREE
6261RYR1C0007222Cardiovascular Diseases0.0002747267842131BEFREE
6261RYR1C0011989Camurati-Engelmann Syndrome0.0002747267842131BEFREE
6261RYR1C0027121Myositis0.0002747267842131BEFREE
6261RYR1C0030443Familial Periodic Paralysis0.0002747267842131BEFREE
6261RYR1C0035086Renal Osteodystrophy0.0002747267842131BEFREE
6261RYR1C0036439Scoliosis, unspecified0.0002747267842131BEFREE
6261RYR1C0036572Seizures0.0002747267842131BEFREE
6261RYR1C0040100Thymoma0.0002747267842131BEFREE
6261RYR1C0149721Left Ventricular Hypertrophy0.0002747267842131BEFREE
6261RYR1C0153690Secondary malignant neoplasm of bone0.0002747267842131BEFREE
6261RYR1C0155338Total ophthalmoplegia0.0002747267842131BEFREE
6261RYR1C0231528Myalgia0.0002747267842131BEFREE
6261RYR1C0238358Hypokalemic periodic paralysis0.0002747267842131BEFREE
6261RYR1C0242379Malignant neoplasm of lung0.0002747267842131BEFREE
6261RYR1C0263992Exertional rhabdomyolysis (disorder)0.0002747267842131BEFREE
6261RYR1C0264162Camptocormia0.0002747267842131BEFREE
6261RYR1C0270971Floppy infant syndrome0.0002747267842131BEFREE
6261RYR1C0340485Familial ventricular tachycardia0.0002747267842131BEFREE
6261RYR1C0343239Benign congenital hypotonia0.0002747267842131BEFREE
6261RYR1C0424295Hyperactive behavior0.0002747267842131BEFREE
6261RYR1C0600139Prostate carcinoma0.0002747267842131BEFREE
6261RYR1C0684249Carcinoma of lung0.0002747267842131BEFREE
6261RYR1C0743841Disorder characterized by fever0.0002747267842131BEFREE
6261RYR1C0750403Proximal weakness0.0002747267842131BEFREE
6261RYR1C0947912Myasthenias0.0002747267842131BEFREE
6261RYR1C1279412periodic paralysis (finding)0.0002747267842131BEFREE
6261RYR1C1302995Congenital Fibrosis of the Extraocular Muscles0.0002747267842131BEFREE
6261RYR1C1306460Primary malignant neoplasm of lung0.0002747267842131BEFREE
6261RYR1C1319466Barber Say syndrome0.0002747267842131BEFREE
6261RYR1C1533847Disorder of skeletal muscle0.0002747267842131BEFREE
6261RYR1C18551263-Methylglutaconic Aciduria Type IV0.0002747267842131BEFREE
6261RYR1C1857276Trichohepatoenteric Syndrome0.0002747267842131BEFREE
6261RYR1C1857941Brooke-Spiegler syndrome0.0002747267842131BEFREE
6261RYR1C3203102Idiopathic pulmonary arterial hypertension0.0002747267842131BEFREE
6261RYR1C3250443MYOTONIC DYSTROPHY 10.0002747267842131BEFREE